Status:
COMPLETED
Could Wearing Face Mask Have Affected Demodex Parasite
Lead Sponsor:
Nurhan Döner Aktaş
Conditions:
Pandemic, COVID-19
Demodex Infestation
Eligibility:
All Genders
19-45 years
Phase:
NA
Brief Summary
This study aimed to examine whether wearing masks by healthy individuals during the Covid-19 pandemic created an environment for Demodex mites, by comparing it with the control group. In order to dete...
Detailed Description
The study was carried out on March 15.2021 and the data collection was completed within 6 months. For the randomization of the participants, they were first stratified according to age and then the pa...
Eligibility Criteria
Inclusion
- Individuals (ı) who wore N95/FFP2 masks during the whole working hours, and only took off it for less than 1 hour; (ıı) those who wore a 3-ply surgical mask during all working hours, only took it off for less than 1 hour (ııı) people who wore a 3-ply surgical mask for less than 3 days a week, less than 2 hours a day and spending time mostly at home during the day or plus those who worked alone all day in their rooms and who wear a 3-ply surgical mask for less than 1 hour during the day as required.
- (The third group represented the control group (the control group was comprised of individuals who presented to the hospital during the study period, since there was no one without mask during the day).
Exclusion
- Having dermatosis (acne, acne rosacea, seborrheic dermatitis) and/or other dermatological diseases associated with the presence of Demodex mites, receiving or having been receiving treatment for Demodex-associated dermatosis (topical and/or systemic)
- Using face wash gel and/or cologne, which prevents the life of Demodex mites, cosmetic cream with pore-clogging feature, applying disinfectant
- Being obese (BMI\> 30)
- Consuming regular alcohol use,
- Taking oral therapy that suppresses the immune system, or using creams with immunological effects when applied topically on the face
- Developing any skin complaints with wearing masks.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06185699
Start Date
March 15 2021
End Date
September 15 2021
Last Update
December 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Izmir Katip Çelebi University Atatürk Research and Trainig Hospital
Izmir, Turkey (Türkiye), 35000